Article ID Journal Published Year Pages File Type
8790010 Urologic Oncology: Seminars and Original Investigations 2018 11 Pages PDF
Abstract
MCT1 and MCT4 are prognostic biomarkers for patients with ccRCC or those receiving targeted therapy. High expression of these 2 proteins predicts reduced PFS in these patients.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis
Authors
, , , , , , , , , , ,